Clinical trial

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

NCT00090402 · Oregon Health and Science University, Other · Completed

Key facts

NCT number NCT00090402
Title Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
Official title Fish Oil and Alpha Lipoic Acid in Mild Alzheimer's Disease
Lead sponsor Oregon Health and Science University, Other
Collaborators National Institute on Aging (NIA) NIH National Center for Research Resources (NCRR)
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Alzheimer's Disease, Oxidative Stress, Dementia, Hyperlipidemia, Inflammation
Intervention type Dietary Supplement, Other
Interventions Fish Oil, Lipoic Acid, Fish Oil Placebo, Lipoic Acid Placebo
Enrollment 39
Start date Apr 1, 2004
Primary completion Jan 3, 2006
Completion Aug 1, 2007
First posted Aug 26, 2004
Last update posted Jul 21, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies